EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study.
Ratziu V, Rinella ME, Neuschwander-Tetri BA, Lawitz E, Denham D, Kayali Z, Sheikh A, Kowdley KV, Desta T, Elkhashab M, DeGrauw J, Goodwin B, Ahmad A, Adda N.
Ratziu V, et al. Among authors: ahmad a.
J Hepatol. 2022 Mar;76(3):506-517. doi: 10.1016/j.jhep.2021.10.018. Epub 2021 Nov 3.
J Hepatol. 2022.
PMID: 34740705
Free article.